The changing landscape of cancer treatment is poised for a major shift, largely driven by the rise of "authentic" oncology pharmaceuticals. This method emphasizes precision and tailored medicine, moving beyond established chemotherapy and broader radiation therapy. Future platforms will likely integrate cutting-edge diagnostics to detect unique gen